Skip to search.
 FTSE 100 Down 1.72%

Sangamo Biosciences Inc. (SGMO)

-NasdaqGS
15.68 Down 0.18(1.13%) 20:59
|After Hours: : 15.68 0.00 (0.00%) 21:36
Add to Portfolio
Prev Close:15.86
Open:15.73
Bid:14.90 x 1200
Ask:17.00 x 1800
1y Target Est:25.50
Beta:2.42
Earnings Date:4 May - 8 May (Est.)
Day's Range:15.64 - 16.18
52wk Range:9.39 - 19.25
Volume:551,279
Avg Vol (3m):958,180
Market Cap:1.08b
P/E (ttm):N/A
EPS (ttm):-0.39
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for SGMO at this time.

Comparison

Symbol% ChgMkt Cap
SGMODown 1.13%1.08b
AMGNDown 2.71%121.30b
LLYDown 1.65%77.05b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):23.92
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.57
Quarterly EPS Est (Mar-15) :-0.14
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of engineered DNA-binding proteins as novel therapeutic products for unmet medical needs in the United States. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback